Hemophilia Treatment Market – Disease Type (Hemophilia A, Hemophilia B), Product (Recombinant Factor Concentrates), Patient (Pediatric, Adult), Treatment (Prophylaxis, On Demand), Therapy, Drug Class, Route of Administration, End-use – Global Forecast 2024 – 2032
Report ID: GMI2772
Selected License: | $4,850 |
Discount: | $728 |
Call us or write to us: